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Abstract: MAP kinases of the ERK family play important roles in oocyte maturation, fertilization, and early
embryo development. The role of the signaling pathway involving ERK5 MAP kinase during meiotic and mitot-
ic M-phase of the cell cycle is not well known. Here, we studied the localization of the phosphorylated, and thus
potentially activated, form of ERK5 in mouse maturing oocytes and mitotically dividing early embryos. We show
that phosphorylation/dephosphorylation, i.e. likely activation/inactivation of ERK5, correlates with M-phase
progression. Phosphorylated form of ERK5 accumulates in division spindle of both meiotic and mitotic cells,
and precisely co-localizes with spindle microtubules at metaphase. This localization changes drastically in the
anaphase, when phospho-ERK5 completely disappears from microtubules and transits to the cytoplasmic gran-
ular, vesicle-like structures. In telophase oocytes it becomes incorporated into the midbody. Dynamic changes in
the localization of phospho-ERK5 suggests that it may play an important role both in meiotic and mitotic divi-
sion. (Folia Histochemica et Cytobiologica 2011, Vol. 49, No. 3, 528–534)
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Introduction
MAPK (Mitogen Activated Protein Kinase) signal-
ing pathways are implicated in the regulation of a wide
range of cellular processes such as proliferation, dif-
ferentiation, and apoptosis [1]. Their function has
been analyzed in various somatic cells [2–6], as well
as in oocytes and embryos (e.g. [7, 8]). BMK1/ERK5/
/MAPK7 (Big MAP Kinase 1/Extracellular signal-Reg-
ulated Kinase 5/Mitogen Activated Protein Kinase 7;
further called by us ERK5) is one of the less charac-
terized MAP kinases of the ERK family. ERK5 knock-
-out mice proved that the major developmental func-
tion of this kinase is related to the placental, cephalic,
hindgut, and, importantly, cardiovascular development
[9–13]. Thus, mouse embryos lacking functional ERK5
gene failed to progress beyond E10.5, but until this
developmental stage the cellular proliferation seemed
unperturbed. Further analyses suggested, however, that
ERK5 is activated at G2-M transition, and thus in-
volved in the regulation of mitotic division [2, 14–16].
Details of the mitotic function of this kinase have been
analyzed in somatic cells, but have never been previ-
ously reported in oocytes or in embryonic cells.
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Among the MAP kinases family members studied
so far in oocytes and embryos, only the function of
ERK1 and ERK2 is well known. These two MAP ki-
nases are activated by Mos-MEK1 pathway and are
necessary for the establishment of CSF (CytoStatic
Factor). CSF mediates the arrest of metaphase II
oocytes in the mouse [8, 17] as well as in the frog [18].
Special attention has been paid to ERK1 and ERK2
MAPK pathway since it was shown to be necessary to
sustain the meiotic arrest of maturing vertebrate oo-
cytes, establishment of oocyte polarity, and impact-
ing at the correct size of the polar body (e.g. [19–24]).
In-gel MBP kinase assay performed using mouse oo-
cytes and one-cell embryos proved that ERK1 and
ERK2 activity is high exclusively in oocytes, but un-
detectable during mitotic divisions of early mouse em-
bryos [8, 25]. The same assay showed also that other
MBP (myelin basic protein, i.e. MAPK substrate)
phosphorylating kinases are active both in oocytes and
mitotically dividing embryos [8, 26], suggesting a po-
tential role for other MAP kinases in the regulation of
early embryonic mitosis. ERK5 is likely to fulfill this
role. The evidence supporting the idea of ERK5 in-
volvement both in meiosis and mitosis comes from anal-
yses of MAP kinases substrates. Phosphorylated form
of one of them, i.e. p90Rsk1, was detectable in meioti-
cally dividing mouse oocytes, when ERK1 and ERK2
are fully activated, but also during the first mitosis of
mouse embryo, when these two ERK kinases remain
inactive ([25], our unpublished data). Since p90rsk1 was
shown to be phosphorylated by ERK5 in somatic cells
[3], it is likely that p90rsk1 is activated by the same path-
way during M-phase of oocytes and early embryos.
ERK5-encoding mRNA was detected in unfertilized
oocytes, and in preimplantation embryos up to blas-
tocyst stage, suggesting that the protein could be
present at that stage [7]. The presence of ERK5 pro-
tein in pig oocytes was shown using Western blotting.
However, the precise localization analysis was lack-
ing [27]. Similarly, Wang et al. presented Western blot
analysis of preimplantation mouse embryos (3.5 days
of development) and non-conclusive immunodetec-
tion of active and inactive forms of ERK5 [7].
In the current paper we show that ERK5 is present
in mouse oocytes and early embryos, its activation is pre-
cisely regulated during each of the M-phases studied,
and that its association with both meiotic and mitotic
spindle is highly controlled during M-phase progression.
Material and methods
Ethical issues. All animal studies presented were ap-
proved by Local Ethics Committee No. 1 in Warsaw, Po-
land according to European Union Council Directive 86/
/609/EEC of 24 November 1986. All animals were raised
on the premises.
Collection and culture of oocytes at germinal vesicle
stage. Two- to three-month-old F1 (C57Bl/10 × CBA/H)
female mice were injected intraperitoneally with 10 IU preg-
nant mare serum gonadotrophin (PMSG; Folligon, Inter-
vet, Netherlands) to stimulate the development of ovarian
follicles. Between 48 and 52 hours later the females were
killed by cervical dislocation. Fully grown oocytes arrested
at prophase of the first meiotic division (germinal vesicle
stage [GV]) were released from ovarian follicles. Oocytes
were freed from cumulus cells by pipetting and then cultured
for 2 h in M2 medium (medium M16 buffered with HEPES;
[28]) containing bovine serum albumin (BSA; 4 mg/ml). Oo-
cytes were fixed and subjected to immunofluorescence at GV
stage, at the GVBD (germinal vesicle breakdown), and at
selected, subsequent stages of in vitro maturation.
Collection, parthenogenetic activation of ovulated oo-
cytes and in vitro culture of one- and two-cell embryos,
blastocysts. F1 females were superovulated by injection of
10 IU of eCG and 10 IU of hCG (Intervet, Netherlands)
48–52 hours apart. Ovulated oocytes were collected 17–18
hours after hCG injection and cumulus cells were removed
with hyaluronidase (Sigma Aldrich, Germany, 300 units/ml
PBS). For the parthenogenetic activation, the oocytes were
exposed to 8% ethanol (POCh, Poland) in M2 medium for
8 minutes at room temperature [29], washed carefully and
cultured in M2. Only those oocytes that extruded polar bod-
ies and formed pronuclei were used for further analyses.
Starting at 14 hours after activation embryos were scored
every 10 minutes to determine the timing of the nuclear
envelope breakdown (NEBD) and then collected for fur-
ther analyses at different times after NEBD. Fertilized two-
cell embryos were obtained from superovulated and mated
females 49 hours after hCG. Embryos were collected and
cultured in M2 medium. Starting from 49 hours after hCG,
embryos were observed every 10 minutes to determine the
timing of NEBD and collected for further analyses at differ-
ent times after NEBD. Blastocysts were obtained from uteri
of superovulated and mated females at 90 hours after hCG.
In vitro culture of murine NIH3T3 fibroblasts and C2C12
myoblasts. NIH3T3 fibroblasts were cultured in Dulbec-
co’s modified Eagle’s medium supplemented (DMEM, In-
vitrogen) with 10% fetal calf serum (FCS) and antibiotics
(Invitrogen) at 37°C in 5% CO2. Media were supplemented
with penicillin (100 units/ml) and streptomycin (100 mg/ml).
Cells were fixed 48 hours after plating and processed for
Western blotting or immunodetection of tubulin, ERK5, and
phospho-ERK5 epitopes. C2C12 murine myoblasts cell line
was obtained from the European Collection of Cell Cul-
530 Z Maciejewska et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2011
10.5603/FHC.2011.0074
www.fhc.viamedica.pl
tures (ECACC no. 91031101, passage no. 13). Cells were cul-
tured in high-glucose DMEM supplemented with 10% FCS
and antibiotics at 37°C in 5% CO2. Cells were fixed and pro-
cessed for immunodetection of tubulin and phospho-ERK5
epitopes at day 2 after plating, i.e. at the proliferative stage.
Western blotting. Protein samples of NIH3T3 cells were
subjected to electrophoresis in 9% SDS-PAGE gels [30].
Separated proteins were transferred to nitrocellulose mem-
branes (Hybond C, Amersham Biosciences) and probed with
rabbit polyclonal primary antibodies either against ERK5
or phospho-ERK5 (Upstate Biotechnology, USA) at the di-
lution of 1:1,000. Next, a-tubulin was immunodetected with
mouse monoclonal antibody (Sigma Aldrich, Germany).
Antigen–antibody complexes were revealed using alkaline
phosphatase conjugated anti-rabbit or anti-mouse second-
ary antibody (diluted 1:20,000, Jackson ImmunoResearch,
USA) in combination with Enhanced Chemifluorescence
reagent (ECF; Amersham Biosciences). Signal quantifica-
tion was performed using ImageQuant 5.2 software (Am-
ersham Biosciences).
Immunofluorescence. NIH3T3 cells and C2C12 myoblasts
plated and cultured on glass coverslips were fixed in 3.7%
paraformaldehyde in PBS for 10 min at room temperature
and permeabilized with 0.1% Triton X100 in PBS for 5 min.
Oocytes and embryos were fixed in 3.7% paraformaldehyde
in PBS for 30 min at room temperature and permeabilized
with 0.1% Triton X100 in PBS for 5 min. Non-specific bind-
ing was blocked by 1 h long treatment with 3% BSA in PBS.
Rabbit polyclonal antibodies against phospho-ERK5 (Up-
state Biotechnology, USA) were used at the dilution of 1:200
and the incubation was performed overnight at 4°C. Next,
a-tubulin was immunodetected with mouse monoclonal
antibody (Sigma Aldrich, Germany) followed by FITC-la-
beled anti-rabbit and TRITC-labeled anti-mouse antibod-
ies (Jackson ImmunoResearch, USA). Chromatin was vi-
sualized either with chromomycin A3 (Sigma Aldrich, Ger-
many) diluted 1:1.000 in PBS with 5 mM MgCl2 for 0.5 h at
room temperature or propidium iodide present in mount-
ing medium (Vector Laboratories, USA). Samples incubat-
ed in chromomycin A3 were mounted in Citifluor (Citiflu-
or Ltd, UK) on glass slides. Immunofluorescence analysis
was accompanied by appropriate negative controls, i.e. sam-
ples were not subjected to the primary antibodies, but in-
stead they were incubated in 3% BSA in PBS. All samples
were examined with laser scanning confocal microscope
(Axiovert 100M, Carl Zeiss Jena, Germany) and processed
using Adobe Photoshop 6.0.
Results and discussion
Since ERK5 is known to be phosphorylated upon
M-phase in human cells [2, 16, 31], and its role in mam-
malian meiosis is virtually unknown, we decided to
begin characterization of this MAP kinase in mouse
oocytes by following the dynamics in its phosphoryla-
tion state using a specific anti-phospho-ERK5
(P-ERK5) antibody.
In germinal vesicle (GV) stage oocytes (meiotic
prophase I) phosphorylated ERK5 is absent from the
GV and is detected as a background staining within
the cytoplasm (Figure 1, GV). Following M-phase
entry, upon germinal vesicle breakdown (GVBD), the
P-ERK5 signal becomes detectable close to condens-
ing bivalents (Figure 1, GVBD + 1 h). This staining
increases with the progression of the prometaphase
and reflects organization of microtubules forming
meiotic spindle around the individualized bivalents.
The intensity of the staining is highest in the vicinity
of the chromosome bivalents (Figure 1, GVBD + 3 h).
In metaphase of the first meiotic division P-ERK5
localizes entirely to the spindle microtubules, and the
background, i.e. cytoplasmic staining, becomes neg-
ligible (Figure 1, metaphase I). At the time of the first
polar body extrusion, at the anaphase I/telophase I
transition, P-ERK5 is no longer detectable on the
spindle microtubules. However, it remains clearly
positioned next to the telophase groups of chromatin
and within the midbody. Concomitantly the decrease
in the cytoplasmic staining is observed (Figure 1, te-
lophase I). During the metaphase of the second mei-
otic division P-ERK5 staining becomes again local-
ized exclusively to the meiotic spindle, as it was dur-
ing the metaphase I (Figure 1, metaphase II). At this
stage the cytoplasmic staining is also reduced to a min-
imum. Thus, the P-ERK5 localization in oocytes un-
dergoing meiotic maturation shows that active form
of ERK5 MAP kinase localizes specifically to the mei-
otic spindle. The affinity of ERK5 to the spindle mi-
crotubules manifests very early upon GVBD and per-
sists during the long metaphase I which takes about
8 hours. The progressive incorporation of ERK5 to
the spindle is manifested by its total disappearance
from the cytoplasm when the meiotic spindle is fully
assembled both in metaphases I and II. Microtubule-
associated localization of other MAP kinases, and
some of their activators, has been reported. MEK1/2
kinase, which activates ERK1/2, was shown to be lim-
ited to the meiotic spindle, and its active form was
shown to be located within the midbody during
anaphase [32, 33]. On the other hand, ERK1/2 MAP
kinases were detectable at the spindle poles. ERK3
was also recently reported to co-localize to spindle
microtubules, although the activation of this kinase
was not investigated [34]. The localization and acti-
vation of ERK5 in mouse oocytes and early embryos
has not been precisely studied to date; but, its expres-
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sion was shown in pig oocytes [27], and mouse preim-
plantation embryos [7]. However, images of ERK5
and P-ERK5 localization in mouse blastocysts pre-
sented by Wang et al. showed high and uniform sig-
nal within the cytoplasm of inner cell mass and tro-
phectoderm cells [7], clearly different from that in
the oocytes studied by us. This prompted us to ana-
lyze the P-ERK5 localization also in preimplantation
mouse embryos.
To verify the specificity of the antibody used, we
performed Western blotting and immunolocalization
analyses of total ERK5 and P-ERK5 in murine so-
matic NIH3T3 cells. Similarly as presented by others
(e.g. [2, 16]), we detected a clear increase in the phos-
phorylated, up-shifted form of ERK5 in nocodazole-
synchronized, i.e. mitotic cells. This result was ob-
tained using both anti-total ERK5 (Figure 2A, ERK5)
and anti-P-ERK5 antibody (Figure 2B, P-ERK5).
Figure 1. P-ERK5 localization in maturing mouse oocytes. Oocytes were analyzed at GV stage, and then during the
formation of the metaphase plate and spindle of the first meiotic division (1 and 3 h after GVBD), at metaphase I
(5 h after GVBD), telophase I (8 h after GVBD) and at metaphase II (9 h after GVBD). Top row — immunolocalization
of P-ERK (green) and chromatin visualization (blue), overlay; bottom row — immunolocalization of P-ERK (green)
Figure 2. P-ERK5 in murine NIH3T3 fibroblasts and C2C12 myoblasts. A. Immunoblotting of ERK5 and P-ERK5 in
lysates of asynchronously growing and nocodazole synchronized NIH3T3 fibroblasts. Note the presence of upper, slow-
migrating, i.e. phosphorylated form of ERK5 in nocodazole treated cells. Immunodetection of a-tubulin was performed to
show the equal loading of the analyzed samples; B. Immunolocalization of P-ERK5 in asynchronously growing NIH3T3
fibroblasts; C. Immunolocalization of P-ERK5 in asynchronously growing C2C12 myoblasts. NIH3T3 and C2C12 cells
were fixed in interphase, prophase and metaphase. Top row — immunolocalization of P-ERK5 (green), a-tubulin (red),
and visualization of chromatin (blue), overlay; middle row — immunolocalization of a-tubulin (red); bottom row —
immunolocalization of P-ERK5 (green). Note the P-ERK accumulation in prophase nuclei and spindle and chromosome
localization in metaphase. White asterisks indicate interphase nuclei lacking P-ERK5 staining
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Importantly, the phosphorylated form of ERK5 lo-
calized not only to the meiotic spindles, as described
above, but also to the mitotic spindle, as shown in
mouse NIH3T3 cells (Figure 2B) and C2C12 myo-
blasts (Figure 2C). In the interphase NIH3T3 and
C2C12 cells, a low cytoplasmic staining is detectable,
while the nuclei are entirely devoid of P-ERK5 (Fig-
ures 2B and 2C, white asterisks). The nuclear local-
ization of P-ERK5 becomes clear during prophase
(Figure 2B and C, prophase). Further, in M-phase,
the P-ERK5 staining is restricted to the mitotic spin-
dle only in NIH3T3 cells (Figure 2B, M-phase), while
in murine myoblasts C2C12 P-ERK5 colocalizes not
only to the spindle, but also to chromosomes (Figure
2C, M-phase). Thus, Western blotting and also im-
munolocalization confirm that the signal detected in
murine oocytes corresponds to the phosphorylated
form of ERK5.
To perform precise analysis of P-ERK5 during
M-phase progression in embryonic cells we studied
the well-characterized model of mitotically dividing
mouse one-cell embryos. The first mitotic division of
mouse embryo can serve, due to its duration of ap-
proximately 120 minutes, as a useful tool to study the
mitotic events [35–39]. This feature allowed us to pre-
cisely analyze the localization and dynamics of ERK5
activation in M-phase. At metaphase of the first mi-
totic division of one-cell embryos, similarly as was
shown for oocytes, P-ERK5 perfectly colocalized to the
spindle microtubules (Figure 3A, metaphase). More-
over, the cytoplasmic staining was not detected.
As soon as the anaphase started the pattern of
P-ERK5 localization changed dramatically. First of
all, the P-ERK5 signal was lost from the microtubules,
and became visible as a diffused cloud around the
spindle (Figure 3A, early anaphase). This signal dis-
persed during the progression to late anaphase and
beginning of cytokinesis (Figure 3A, late anaphase).
Concomitantly, the cytoplasmic staining increased
(Figure 3A, early and late anaphase). Thus, follow-
ing the metaphase-anaphase transition, P-ERK5 is no
longer present on spindle microtubules, but seems to
disperse around the anaphase spindle and further
within the cytoplasm. Similar localization of P-ERK5
within the mitotic spindle was observed in two cell
stage blastomeres (Figure 3B), and at further stages
of preimplantation development (Figure 3C).
These results show that: 1) ERK5 is phosphory-
lated upon M-phase entry in meiosis and mitosis;
2) in both cases it localizes to the metaphase spindle
microtubules; 3) and disappears from the spindle in
early anaphase. Such localization suggests that ERK5
plays a similar function in spindle assembly/function
in oocytes, embryos and somatic cells.
Figure 3. P-ERK5 localization in preimplantation mouse embryos. A. One-cell mouse parthenogenetic embryos fixed at
metaphase and anaphase of first mitotic division. B. Two-cell mouse embryo fixed at metaphase of the second mitotic
division. C. Mitotically dividing inner cell mass in blastocyst. Top row — immunolocalization of P-ERK5 (green),
a-tubulin (red), and visualization of chromatin (blue), overlay; middle row — immunolocalization of a-tubulin (red);
bottom row — immunolocalization of P-ERK5 (green)
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ERK5/ BMK1/MAPK7 belongs to the subfamily of
the MAP kinase family in mammals and it has some
characteristic features: a large C-terminus and a unique
loop sequence [40]. Mammalian ERK5 has been shown
to be activated by oxidative stress, hyperosmolarity, and
several growth factors, including epidermal growth fac-
tor and nerve growth factor [40–45]. The mitotic func-
tion of ERK5 was suggested by the results of experi-
ments focusing on both non-transformed cells such as
fibroblasts and transformed cell lines such as HeLa
cells. In HeLa cells, the expressing of constitutively
active MEK5, and as a result the activation of ERK5,
leads to an increase in the number of mitotic cells [2].
On the other hand, the use of the dominant negative
form of ERK5, or siRNA suppressing ERK5 expres-
sion reduced mitotic index of analyzed cells [2]. More-
over, siRNA depletion of ERK5 decreases cell surviv-
al of mitotically dividing cells [14]. However, the fact
that mouse embryos lacking functional ERK5 gene are
able to survive until approximately E10.5 strongly sug-
gests that ERK5 function can be replaced by another
enzyme. Other MAP kinases, like ERK1 and ERK2,
are candidates for such a function. Despite the fact
that localization of ERK1 and ERK2 does not pre-
cisely reflect the P-ERK5 position within the mitotic
spindle, it is well known that these kinases play a cru-
cial role in meiotic spindle organization and function
[8]. Analyses of oocytes from mice deficient in Mos
kinase, an upstream ERK1/2 activating kinase, proved
that ERK1/2 regulate microtubule dynamics [17, 19,
20]. Recent discoveries of ERK3 localization and func-
tion in mouse oocytes identify a new candidate, which
together with ERK1/2 and ERK5, might be involved
in the regulation of spindle dynamics [34]. ERK3 was
shown to be crucial for successful mouse development,
but again, similarly as it was described for ERK5 knock-
-out mice, ERK3 deficiency did not prohibit mitotic
divisions of the vast majority of embryonic tissues [46].
This kinase, however, similarly to ERK1/2 and ERK5,
has been shown to be phosphorylated during M-phase
entry and dephosphorylated at metaphase/anaphase
transition [47]. The ERK4-deficient mice also did not
reveal any significant mitotic phenotype; moreover,
these animals were not only viable but also fertile [48].
Thus, only the perturbation of the activity ERK1/2
MAP kinases pathway, as shown by Mos knock-out
mice analyses, has fatal consequences for the mouse
fertility impacting at the oocyte maturation [17, 49, 50].
Mos knockout does not influence the mouse embryo
development and animal viability probably due to
ERK1 and ERK2 activation via Ras/Raf pathway [51].
However, it is possible that other MAPK, such as
ERK5, may also act to rescue Mos deficiency follow-
ing fertilization. Further studies will be necessary to
solve this issue.
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